Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print February 15, 2007
DOI: 10.2337/db06-1644

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1644v1
56/5/1421    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kita, T.
Right arrow Articles by Ishibashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kita, T.
Right arrow Articles by Ishibashi, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells

Takeshi Kita1, Yasuaki Hata1, Muneki Miura1, Shuhei Kawahara1, Shintaro Nakao1, and Tatsuro Ishibashi1

1Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Correspondence: hatachan{at}med.kyushu-u.ac.jp

Connective tissue growth factor (CTGF) level is elevated in eyes with proliferative vitreoretinal diseases such as proliferative diabetic retinopathy (PDR) and proliferative vitreo-retinopathy (PVR) as we previously reported, but its functional characteristics on vitreoretinal cells is yet to be clarified. In this study, we demonstrated a growth promoting effect of CTGF on cultured hyalocytes and retinal pigment epithelial cells (BRPEs) with the induction of p44/p42 MAPK phosphorylation and [3H]-thymidine incorporation. CTGF also stimulated the synthesis of fibronectin by hyalocytes and BRPEs without significant effect on collagen gel contraction by these cells. On the other hand, CTGF had no direct effects on the proliferation, migration or in vitro tube formation by vascular endothelial cells. Nevertheless, CTGF promoted vascular endothelial growth factor (VEGF) gene expression by hyalocytes and BRPEs. While the concentrations of both CTGF and VEGF in the human vitreous samples with proliferative vitreoretinal diseases were elevated, there was no significant correlation between these concentrations. These findings indicate that CTGF appears to be involved in the formation of proliferative membranes without direct regulation of their cicatricial contraction in the pathogenesis of proliferative vitreoretinal diseases. Whereas CTGF might have no direct effects, or minimal if any, on retinal neovascularization, it is possible that CTGF has indirect effects by modulating the expression of VEGF.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.